chr2-71124482-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS2
The NM_032601.4(MCEE):āc.102C>Gā(p.Pro34Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00679 in 1,614,128 control chromosomes in the GnomAD database, including 56 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.0061 ( 6 hom., cov: 33)
Exomes š: 0.0069 ( 50 hom. )
Consequence
MCEE
NM_032601.4 synonymous
NM_032601.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.470
Genes affected
MCEE (HGNC:16732): (methylmalonyl-CoA epimerase) The product of this gene catalyzes the interconversion of D- and L-methylmalonyl-CoA during the degradation of branched chain amino acids. odd chain-length fatty acids, and other metabolites. Mutations in this gene result in methylmalonyl-CoA epimerase deficiency, which is presented as mild to moderate methylmalonic aciduria. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 2-71124482-G-C is Benign according to our data. Variant chr2-71124482-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 195391.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1, Benign=4}.
BP7
Synonymous conserved (PhyloP=0.47 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 6 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MCEE | NM_032601.4 | c.102C>G | p.Pro34Pro | synonymous_variant | 2/3 | ENST00000244217.6 | NP_115990.3 | |
MCEE | XM_047446039.1 | c.102C>G | p.Pro34Pro | synonymous_variant | 2/3 | XP_047301995.1 | ||
MCEE | XM_005264613.3 | c.102C>G | p.Pro34Pro | synonymous_variant | 2/3 | XP_005264670.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MCEE | ENST00000244217.6 | c.102C>G | p.Pro34Pro | synonymous_variant | 2/3 | 1 | NM_032601.4 | ENSP00000244217.5 | ||
MCEE | ENST00000486135.1 | c.-184C>G | 5_prime_UTR_variant | 3/3 | 3 | ENSP00000441569.1 | ||||
MCEE | ENST00000494660.6 | c.-184C>G | 5_prime_UTR_variant | 2/2 | 2 | ENSP00000437361.1 | ||||
MCEE | ENST00000413592.5 | c.-31C>G | upstream_gene_variant | 2 | ENSP00000391140.1 |
Frequencies
GnomAD3 genomes AF: 0.00612 AC: 932AN: 152180Hom.: 6 Cov.: 33
GnomAD3 genomes
AF:
AC:
932
AN:
152180
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00577 AC: 1448AN: 250870Hom.: 9 AF XY: 0.00569 AC XY: 772AN XY: 135716
GnomAD3 exomes
AF:
AC:
1448
AN:
250870
Hom.:
AF XY:
AC XY:
772
AN XY:
135716
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00686 AC: 10022AN: 1461830Hom.: 50 Cov.: 34 AF XY: 0.00678 AC XY: 4932AN XY: 727210
GnomAD4 exome
AF:
AC:
10022
AN:
1461830
Hom.:
Cov.:
34
AF XY:
AC XY:
4932
AN XY:
727210
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00611 AC: 931AN: 152298Hom.: 6 Cov.: 33 AF XY: 0.00685 AC XY: 510AN XY: 74462
GnomAD4 genome
AF:
AC:
931
AN:
152298
Hom.:
Cov.:
33
AF XY:
AC XY:
510
AN XY:
74462
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 08, 2023 | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 19, 2015 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 02, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2024 | MCEE: BP4, BP7, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at